Annual CFO
-$145.59 M
-$33.28 M-29.63%
31 December 2023
Summary:
Autolus Therapeutics annual cash flow from operations is currently -$145.59 million, with the most recent change of -$33.28 million (-29.63%) on 31 December 2023. During the last 3 years, it has fallen by -$27.73 million (-23.52%). AUTL annual CFO is now -1378.19% below its all-time high of -$9.85 million, reached on 30 September 2016.AUTL Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$76.74 M
-$25.66 M-50.23%
30 September 2024
Summary:
Autolus Therapeutics quarterly cash flow from operations is currently -$76.74 million, with the most recent change of -$25.66 million (-50.23%) on 30 September 2024. Over the past year, it has dropped by -$51.91 million (-209.02%). AUTL quarterly CFO is now -737.96% below its all-time high of -$9.16 million, reached on 31 December 2021.AUTL Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$193.17 M
-$36.55 M-23.34%
30 September 2024
Summary:
Autolus Therapeutics TTM cash flow from operations is currently -$193.17 million, with the most recent change of -$36.55 million (-23.34%) on 30 September 2024. Over the past year, it has dropped by -$47.58 million (-32.68%). AUTL TTM CFO is now -628.45% below its all-time high of -$26.52 million, reached on 31 March 2019.AUTL TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AUTL Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -209.0% | -32.7% |
| 3 y3 years | -23.5% | -738.0% | -63.9% |
| 5 y5 years | -43.5% | -130.7% | -90.3% |
AUTL Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -29.6% | at low | -738.0% | at low | -80.7% | at low |
| 5 y | 5 years | -43.5% | at low | -738.0% | at low | -95.1% | at low |
| alltime | all time | -1378.2% | at low | -738.0% | at low | -628.5% | at low |
Autolus Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$76.74 M(+50.2%) | -$193.17 M(+23.3%) |
| June 2024 | - | -$51.08 M(+26.1%) | -$156.62 M(+9.0%) |
| Mar 2024 | - | -$40.51 M(+63.1%) | -$143.68 M(-1.3%) |
| Dec 2023 | -$145.59 M(+29.6%) | -$24.83 M(-38.2%) | -$145.59 M(+7.6%) |
| Sept 2023 | - | -$40.19 M(+5.4%) | -$135.32 M(+6.5%) |
| June 2023 | - | -$38.15 M(-10.1%) | -$127.04 M(+6.1%) |
| Mar 2023 | - | -$42.42 M(+191.2%) | -$119.70 M(+6.6%) |
| Dec 2022 | -$112.31 M(-4.7%) | -$14.57 M(-54.3%) | -$112.31 M(+5.1%) |
| Sept 2022 | - | -$31.90 M(+3.6%) | -$106.90 M(-2.6%) |
| June 2022 | - | -$30.81 M(-12.1%) | -$109.75 M(-5.0%) |
| Mar 2022 | - | -$35.03 M(+282.5%) | -$115.55 M(-2.0%) |
| Dec 2021 | -$117.86 M | -$9.16 M(-73.6%) | -$117.86 M(-13.6%) |
| Sept 2021 | - | -$34.75 M(-5.1%) | -$136.43 M(-3.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2021 | - | -$36.61 M(-2.0%) | -$140.75 M(+7.4%) |
| Mar 2021 | - | -$37.34 M(+34.7%) | -$131.07 M(+11.3%) |
| Dec 2020 | -$117.76 M(+16.0%) | -$27.73 M(-29.0%) | -$117.76 M(-4.5%) |
| Sept 2020 | - | -$39.06 M(+45.0%) | -$123.30 M(+13.4%) |
| June 2020 | - | -$26.93 M(+12.1%) | -$108.72 M(+9.8%) |
| Mar 2020 | - | -$24.03 M(-27.8%) | -$99.00 M(-2.4%) |
| Dec 2019 | -$101.48 M(+412.9%) | -$33.27 M(+35.9%) | -$101.48 M(+48.8%) |
| Sept 2019 | - | -$24.49 M(+42.3%) | -$68.22 M(+56.0%) |
| June 2019 | - | -$17.21 M(-35.1%) | -$43.73 M(+64.9%) |
| Mar 2019 | - | -$26.52 M | -$26.52 M |
| Dec 2018 | -$19.79 M(-37.3%) | - | - |
| Sept 2018 | -$31.54 M(+92.8%) | - | - |
| Sept 2017 | -$16.36 M(+66.1%) | - | - |
| Sept 2016 | -$9.85 M | - | - |
FAQ
- What is Autolus Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Autolus Therapeutics?
- What is Autolus Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Autolus Therapeutics?
- What is Autolus Therapeutics quarterly CFO year-on-year change?
- What is Autolus Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Autolus Therapeutics?
- What is Autolus Therapeutics TTM CFO year-on-year change?
What is Autolus Therapeutics annual cash flow from operations?
The current annual CFO of AUTL is -$145.59 M
What is the all time high annual CFO for Autolus Therapeutics?
Autolus Therapeutics all-time high annual cash flow from operations is -$9.85 M
What is Autolus Therapeutics quarterly cash flow from operations?
The current quarterly CFO of AUTL is -$76.74 M
What is the all time high quarterly CFO for Autolus Therapeutics?
Autolus Therapeutics all-time high quarterly cash flow from operations is -$9.16 M
What is Autolus Therapeutics quarterly CFO year-on-year change?
Over the past year, AUTL quarterly cash flow from operations has changed by -$51.91 M (-209.02%)
What is Autolus Therapeutics TTM cash flow from operations?
The current TTM CFO of AUTL is -$193.17 M
What is the all time high TTM CFO for Autolus Therapeutics?
Autolus Therapeutics all-time high TTM cash flow from operations is -$26.52 M
What is Autolus Therapeutics TTM CFO year-on-year change?
Over the past year, AUTL TTM cash flow from operations has changed by -$47.58 M (-32.68%)